Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model
- PMID: 31820278
- DOI: 10.1007/s11010-019-03670-0
Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson's disease mice model
Abstract
Parkinson's disease (PD) is the second common age-related neurodegenerative disease. It is characterized by control loss of voluntary movements control, resting tremor, postural instability, bradykinesia, and rigidity. The aim of the present work is to evaluate curcumin, niacin, dopaminergic and non-dopaminergic drugs in mice model of Parkinson's disease through behavioral, biochemical, genetic and histopathological observations. Mice treated with rotenone rerecorded significant increase in adenosine A2A receptor (A2AR) gene expression, α synuclein, acetylcholinesterase (AchE), malondialdehyde (MDA), angiotensin-II (Ang-II), c-reactive protein (CRP), interleukin-6 (IL-6), caspase-3 (Cas-3) and DNA fragmentation levels as compared with the control group. While, significant decrease in dopamine (DA), norepinephrine (NE), serotonin (5-HT), superoxide dismutase (SOD), reduced glutathione (GSH), ATP, succinate and lactate dehydrogenases (SDH &LDH) levels were detected. Treatment with curcumin, niacin, adenosine A2AR antagonist; ZM241385 and their combination enhanced the animals' behavior and restored all the selected parameters with variable degrees of improvement. The brain histopathological features of hippocampal and substantia nigra regions confirmed our results. In conclusion, the combination of curcumin, niacin and ZM241385 recorded the most potent treatment effect in Parkinsonism mice followed by ZM241385, as a single treatment. ZM241385 succeeded to antagonize adenosine A2A receptor by diminishing its gene expression and ameliorating all biochemical parameters under investigation. The newly investigated agent; ZM241385 has almost the same pattern of improvement as the classical drug; Sinemet®. This could shed the light to the need of detailed studies on ZM241385 for its possible role as a promising treatment against PD. Additionally, food supplements such as curcumin and niacin were effective in Parkinson's disease eradication.
Keywords: Curcumin; Niacin; Parkinson’s disease; Rotenone; ZM241385.
Similar articles
-
Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A2A Receptor Antagonist.Curr Aging Sci. 2022 Feb 3;15(1):65-76. doi: 10.2174/1874609814666210526115740. Curr Aging Sci. 2022. PMID: 34042043
-
Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.Neurosci Lett. 2017 Mar 16;643:89-96. doi: 10.1016/j.neulet.2017.02.036. Epub 2017 Feb 15. Neurosci Lett. 2017. PMID: 28213070
-
Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson's Disease.Int J Mol Sci. 2024 Apr 30;25(9):4903. doi: 10.3390/ijms25094903. Int J Mol Sci. 2024. PMID: 38732120 Free PMC article.
-
The rotenone model of parkinsonism--the five years inspection.J Neural Transm Suppl. 2006;(70):269-72. doi: 10.1007/978-3-211-45295-0_41. J Neural Transm Suppl. 2006. PMID: 17017540 Review.
-
Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?Parkinsonism Relat Disord. 2020 Nov;80 Suppl 1(Suppl 1):S45-S53. doi: 10.1016/j.parkreldis.2020.10.024. Epub 2020 Dec 19. Parkinsonism Relat Disord. 2020. PMID: 33349580 Free PMC article. Review.
Cited by
-
Association between dietary niacin intake and risk of Parkinson's disease in US adults: cross-sectional analysis of survey data from NHANES 2005-2018.Front Nutr. 2024 Jul 18;11:1387802. doi: 10.3389/fnut.2024.1387802. eCollection 2024. Front Nutr. 2024. PMID: 39091685 Free PMC article.
-
New Promising Therapeutic Avenues of Curcumin in Brain Diseases.Molecules. 2021 Dec 31;27(1):236. doi: 10.3390/molecules27010236. Molecules. 2021. PMID: 35011468 Free PMC article. Review.
-
Control of Reactive Oxygen Species for the Prevention of Parkinson's Disease: The Possible Application of Flavonoids.Antioxidants (Basel). 2020 Jul 3;9(7):583. doi: 10.3390/antiox9070583. Antioxidants (Basel). 2020. PMID: 32635299 Free PMC article. Review.
-
Biosynthesis of Zinc Oxide Nanoparticles Using Bacillus paramycoides for In Vitro Biological Activities and In Vivo Assessment Against Hepatorenal Injury Induced by CCl4 in Rats.Appl Biochem Biotechnol. 2024 Sep;196(9):5953-5973. doi: 10.1007/s12010-023-04817-y. Epub 2024 Jan 4. Appl Biochem Biotechnol. 2024. PMID: 38175413 Free PMC article.
-
Dietary niacin intake and epilepsy: a cross-sectional study.Epilepsy Behav Rep. 2025 Aug 5;31:100814. doi: 10.1016/j.ebr.2025.100814. eCollection 2025 Sep. Epilepsy Behav Rep. 2025. PMID: 40809740 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous